It's the second time in less than three months that the Waltham-based life sciences firm has announced layoffs.

Thermo Fisher Scientific (NYSE:TMO – Free Report) had its price objective upped by UBS Group from $700.00 to $715.00 in a research note released on Friday morning,Benzinga reports. The brokerage ...

A clear picture of Thermo Fisher Scientific's perception ... segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (22%); and ...

Thermo Fisher Scientific on Thursday forecast annual profit above Wall Street estimates, banking on improved demand for its products and services used in developing therapies, sending its shares up 6.

Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2024 (revenue ...

Thermo Fisher Scientific Inc. (NYSE:TMO), a leading player in the Life Science Tools & Diagnostics sector, has been navigating a complex market landscape characterized by both challenges and ...